Your location:Home page > Program
Search:
Date:
  • All
  • 2020-11-19[Thur]
  • 2020-11-20[Fri]
  • 2020-11-21[Sat]
  • 2020-11-22[Sun]
Hall:
  • All
  • Main Venue
  • Room No. 1
  • Room No. 2
  • Room No. 3
  • Room No. 4
  • Room No. 5
  • Room No. 6
  • Room No. 7
  • Room No. 8
  • Room No. 9
  • Room No. 10
  • Workshop

Room No. 2

2020-11-21 Sat

10:30-12:00 | From lung cancer screening to timely genetic markers testing to immune therapy - How can we globalize a standard approach
Watch live
NO. Time Subject Speaker Organization
1 10:30-11:00

A decade after NLST, the majority of patients in the "developed countries" don't get appropriate screening, testing, or first-line therapy. Who is to blame?

Ali Musani University of Colorado
2 11:00-11:30

Why are we failing in screening for lung cancer despite national guidelines and extensive coverage from insurance companies and Medicare?coverage from insurance companies and Medicare?

TBD TBD TBD
3 11:30-12:00

Is Europe any better in lung cancer screening, proper genetic testing and immune therapies?

JAVIER FLANDES Madrid - Fundacion Jimenez Diaz, Spain